David Loasby
- SEC CIK
- 0001775863
- Latest filing
- Feb 13, 2026
HRTX holding history
Heron Therapeutics, Inc. in every 13F filed by David Loasby, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HRTX overviewAll 13F holders of HRTXFull Q4 2025 holdings
- Shares (Q4 2025)
- 16,000
- Value
- $23.8K
- % of portfolio
- <0.1%
- Quarters held
- 5
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 16,000 | $23.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 16,000 | $21.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 16,000 | $27.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 16,000 | $29.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 16,000 | $24.8K | <0.1% | +16,000 | New | Holders |